SCHEMBL19954192

SCHEMBL19954192

CCCC(C)N[C@H](C)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.61
CYP3A4 P08684 2/20 0.48
CASR P41180 2/20 0.48
CHRM2 P08172 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CHRM1 P11229 1/20 0.48
SMPD1 P17405 1/20 0.48
DRD1 P21728 1/20 0.48
TBXA2R P21731 1/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
ADRA1A P35348 1/20 0.48
OPRM1 P35372 1/20 0.48
DRD3 P35462 1/20 0.48
HTR2B P41595 1/20 0.48
SLC6A3 Q01959 1/20 0.48
KCNH2 Q12809 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19563117 1.00 SIGMAR1 (0.61) SIGMAR1CYP3A4CASRCHRM2HTR1A
SCHEMBL8586185 0.87 SIGMAR1 (0.56) SIGMAR1CYP3A4CASRCHRM2HTR1A
SCHEMBL20848073 0.85 SIGMAR1 (0.54) SIGMAR1CYP3A4CASRCHRM2HTR1A
SCHEMBL5685856 0.85 SIGMAR1 (0.54) SIGMAR1CYP3A4CASRCHRM2HTR1A
SCHEMBL5321390 0.85 SIGMAR1 (0.54) SIGMAR1CYP3A4CASRCHRM2HTR1A
SCHEMBL9275296 0.85 SIGMAR1 (0.54) SIGMAR1CYP3A4CASRCHRM2HTR1A
SCHEMBL172344 0.83 SIGMAR1 (0.66) SIGMAR1CYP3A4CASRCHRM2HTR1A
SCHEMBL17695117 0.82 SIGMAR1 (0.59) SIGMAR1CYP3A4CASRCHRM2HTR1A
SCHEMBL19954227 0.81 ALDH1A1 (0.50) SIGMAR1HTR1ALMNAMEN1KMT2A
SCHEMBL20847996 0.81 SIGMAR1 (0.68) SIGMAR1CYP3A4HTR1AADRA2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914740-B2 Tricyclic pyrido-carboxamide derivatives as rock inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-13 US disclosed